Talaris Therapeutics
Louisville, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
SI
Suzanne IldstadFounder
SR
Scott RequadtExecutive
GM
Geoff MackayNamed on SEC filing
FN
Francois NaderNamed on SEC filing
Board
SA
Sandip AgarwalaBoard director
MM
Mark McDadeBoard director
NG
Nick GalakatosBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$115M disclosed across 1 round · 2020
▶$115MraisedOct 2020 · 24 investors · BiotechnologyRule 506(b)
▶$115MraisedOct 2020 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sandip AgarwalaDirector
- Scott RequadtExecutive Officer, Director
- Geoff MackayDirector
- Francois NaderDirector
- Mark McDadeDirector
- Nick GalakatosDirector
- Suzanne IldstadExecutive Officer, Director
- Offering amount
- $115M
- Amount sold
- $115M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Talaris Therapeutics?
- Talaris Therapeutics was founded by Suzanne Ildstad.
- Who are Talaris Therapeutics's investors?
- Talaris Therapeutics's investors include Qiming Healthcare.
- How much funding has Talaris Therapeutics raised?
- Talaris Therapeutics has disclosed $115M raised across 1 round.
- Where is Talaris Therapeutics headquartered?
- Talaris Therapeutics is headquartered in Louisville, US.